The total number of records retrieved from this search are 18. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_3350	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result100% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3351	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result80% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3352	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result60% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3353	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result100% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3354	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result90% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3355	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result50% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3356	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result80% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3357	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result50% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3358	Virus nameReovirus	Virus strainRecombinant reovirus T1L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationMutant in L1 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result40% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3359	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result85% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3360	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result85% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3361	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result85% cell viability after 24 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3362	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result90% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3363	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result70% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3364	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result50% cell viability after 48 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3365	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration10 pfu	In-vitro result70% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3366	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration100 pfu	In-vitro result60% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298
IDOV_3367	Virus nameReovirus	Virus strainRecombinant reovirus T3L	Virus genome typeRNA	Virus familyReoviridae	Virus genome modificationSubstitution mutant in T3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman lung cancer cell line	Cell lineH1437	Concentration of cell line1.0E+4 cells per well	In-vitro toxicityNA	AssayCell-titer-glo assay	In-vitro virus concentration1000 pfu	In-vitro result50% cell viability after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis	Immunogenic effectNA	Clinical trialNA	PMID28587298